The role of T helper (T H)17 cells as a double-edged sword in the interplay of infection and autoimmunity with a focus on xenobiotic-induced immunomodulation

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Hemdan, Nasr Y A ^a,b   Abu El Saad, Ahmed M ^b   Sack, Ulrich ^c  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Alexandria University Faculty Of Science   (Egypt)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CALGRANULIN B; CHEMOKINE RECEPTOR CCR6; CXCL3 CHEMOKINE; EOMESODERMIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANZYME B; HEAVY METAL; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 26; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; PROSTAGLANDIN E2; STAT1 PROTEIN; STAT6 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TRANSCRIPTION FACTOR GATA 3; TUMOR NECROSIS FACTOR ALPHA; XENOBIOTIC AGENT;

ALLERGIC PNEUMONITIS; ANTIGEN RECOGNITION; ASPERGILLUS FUMIGATUS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACILLUS SUBTILIS; BACTEREMIA; BACTERIAL CLEARANCE; BACTERIAL LOAD; BONE METABOLISM; BORDETELLA PERTUSSIS; CALCIUM HOMEOSTASIS; CANCER SUSCEPTIBILITY; CANDIDA; CANDIDIASIS; CD8+ T LYMPHOCYTE; CELL FUNCTION; CHEMICAL MODIFICATION; CHLAMYDIA; CITROBACTER; CROHN DISEASE; CYTOKINE PRODUCTION; FRANCISELLA TULARENSIS; GAMMA DELTA T LYMPHOCYTE; GRANULOMA; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOMODULATION; INFECTION; KERATITIS; KLEBSIELLA PNEUMONIAE; LISTERIA MONOCYTOGENES; LONG TERM EXPOSURE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; MUCOSAL IMMUNITY; MURINE ENCEPHALOMYELITIS VIRUS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OCCUPATIONAL EXPOSURE; OSTEOARTHRITIS; OSTEOCLASTOGENESIS; OSTEOPOROSIS; PHAGOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SACCHAROPOLYSPORA RECTIVIRGULA; SALMONELLA; SHIGELLA FLEXNERI; SIGNAL TRANSDUCTION; SIMIAN IMMUNODEFICIENCY VIRUS; SMOKING; STAPHYLOCOCCUS AUREUS; TH17 CELL; TOXOPLASMA GONDII; TRICHINELLA SPIRALIS; TUBERCULOSIS; VIRAL CLEARANCE; VIRUS LOAD; ZINC METABOLISM; BACTERIUM; CELL COMMUNICATION; HELPER CELL; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROBIOLOGY;

AUTOIMMUNITY; BACTERIA; CELL COMMUNICATION; HUMANS; IMMUNOMODULATION; INFECTION; INFLAMMATION; METALS, HEAVY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; TH17 CELLS; XENOBIOTICS;

EID: 84885342343     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/374769     Document Type: Review

References (136)

1. Schiraldi M., Monestier M., How can a chemical element elicit complex immunopathology? Lessons from mercury-induced autoimmunity. Trends in Immunology 2009 30 10 502 509 2-s2.0-70349560009 10.1016/j.it.2009.07.005
2. Pigatto P. D., Guzzi G., Linking mercury amalgam to autoimmunity. Trends in Immunology 2010 31 2 48 49 2-s2.0-75249106327 10.1016/j.it.2009.12.005
3. Hybenova M., Hrda P., Prochazkova J., Stejskal V., Sterzl I., The role of environmental factors in autoimmune thyroiditis. Neuroendocrinology Letters 2010 31 3 283 289 2-s2.0-77955462510
4. Al-Mogairen S. M., Induction of autoimmunity in brown Norway rats by oral and parenteral administration of nickel chloride. Lupus 2010 19 3 262 267 2-s2.0-77749301192 10.1177/0961203309351728
5. Layton A. N., Galyov E. E., Salmonella-induced enteritis: molecular pathogenesis and therapeutic implications. Expert Reviews in Molecular Medicine 2007 9 18 1 17 2-s2.0-34547095503 10.1017/S1462399407000373 (Pubitemid 47103883)
6. Haraga A., Ohlson M. B., Miller S. I., Salmonellae interplay with host cells. Nature Reviews Microbiology 2008 6 1 53 66 2-s2.0-37349110158 10.1038/nrmicro1788 (Pubitemid 350286220)
7. Raychaudhuri S. P., Role of IL-17 in psoriasis and psoriatic arthritis. Clinical Reviews in Allergy and Immunology 2013 44 2 183 193 2-s2.0-84857198108 10.1007/s12016-012-8307-1
8. Kryczek I., Wu K., Zhao E., Wei S., Vatan L., Szeliga W., Huang E., Greenson J., Chang A., Roliński J., Radwan P., Fang J., Wang G., Zou W., IL-17+ regulatory T Cells in the microenvironments of chronic inflammation and cancer. Journal of Immunology 2011 186 7 4388 4395 2-s2.0-79955040909 10.4049/jimmunol.1003251
9. Hemdan N. Y., Birkenmeier G., Wichmann G., Abu El-Saad A. M., Krieger T., Conrad K., Sack U., Interleukin-17-producing T helper cells in autoimmunity. Autoimmunity Reviews 2010 9 11 785 792 2-s2.0-77956189721 10.1016/j.autrev.2010. 07.003
10. Hemdan N. Y., Anti-cancer versus cancer-promoting effects of the interleukin-17-producing T helper cells. Immunology Letters 2013 149 123 133
11. Sawada N., Iwasaki M., Inoue M., Takachi R., Sasazuki S., Yamaji T., Shimazu T., Endo Y., Tsugane S., Long-term dietary cadmium intake and cancer incidence. Epidemiology 2012 23 3 368 376 2-s2.0-84859641124 10.1097/EDE.0b013e31824d063c
12. Van Belle T. L., Esplugues E., Liao J., Juntti T., Flavell R. A., von Herrath M. G., Development of autoimmune diabetes in the absence of detectable IL-17A in a CD8-driven virally induced model. Journal of Immunology 2011 187 6 2915 2922 2-s2.0-80053065321 10.4049/jimmunol.1000180
13. Delgoffe G. M., Pollizzi K. N., Waickman A. T., Heikamp E., Meyers D. J., Horton M. R., Xiao B., Worley P. F., Powell J. D., The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nature Immunology 2011 12 4 295 304 2-s2.0-79952985551 10.1038/ni.2005
14. Ma J., Wang R., Fang X., Ding Y., Sun Z., Critical role of TCF-1 in repression of the IL-17 gene. PLoS ONE 2011 6 9 2-s2.0-80052859027 10.1371/journal.pone.0024768 e24768
15. Hirota K., Duarte J. H., Veldhoen M., Hornsby E., Li Y., Cua D. J., Ahlfors H., Wilhelm C., Tolaini M., Menzel U., Garefalaki A., Potocnik A. J., Stockinger B., Fate mapping of IL-17-producing T cells in inflammatory responses. Nature Immunology 2011 12 3 255 263 2-s2.0-79951677394 10.1038/ni.1993
16. Hemdan N. Y. A., Emmrich F., Adham K., Wichmann G., Lehmann I., El-Massry A., Ghoneim H., Lehmann J., Sack U., Dose-dependent modulation of the in vitro cytokine production of human immune competent cells by lead salts. Toxicological Sciences 2005 86 1 75 83 2-s2.0-26944467207 10.1093/toxsci/kfi177 (Pubitemid 41511352)
17. Hemdan N. Y. A., Emmrich F., Sack U., Wichmann G., Lehmann J., Adham K., Lehmann I., The in vitro immune modulation by cadmium depends on the way of cell activation. Toxicology 2006 222 1-2 37 45 2-s2.0-33646243221 10.1016/j.tox.2006.01.026
18. Hemdan N. Y. A., Emmrich F., Faber S., Lehmann J., Sack U., Alterations of Th1/Th2 reactivity by heavy metals: possible consequences include induction of autoimmune diseases. Annals of the New York Academy of Sciences 2007 1109 129 137 2-s2.0-34848877534 10.1196/annals.1398.015 (Pubitemid 47511352)
19. Hemdan N. Y., The role of interleukin-12 in the heavy metal-elicited immunomodulation: relevance of various evaluation methods. Journal of Occupational Medicine and Toxicology 2008 3 1, article 25 2-s2.0-56749103693 10.1186/1745-6673-3-25
20. Curotto de Lafaille M. A., Lafaille J. J., Natural and adaptive Foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 2009 30 5 626 635 2-s2.0-65549123867 10.1016/j.immuni.2009.05.002
21. Issazadeh-Navikas S., Teimer R., Bockermann R., Influence of dietary components on regulatory T cells. Molecular Medicine 2012 18 1 95 110 2-s2.0-84857006554 10.2119/molmed.2011.00311
22. Maggi L., Santarlasci V., Capone M., Peired A., Frosali F., Crome S. Q., Querci V., Fambrini M., Liotta F., Levings M. K., Maggi E., Cosmi L., Romagnani S., Annunziato F., CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. European Journal of Immunology 2010 40 8 2174 2181 2-s2.0-77956124982 10.1002/eji.200940257
23. Hemdan N. Y., Birkenmeier G., Wichmann G., Key molecules in the differentiation and commitment programof T helper 17 (Th17) cells up-to-date. Immunology Letters 2012 148 97 109
24. Santarlasci V., Maggi L., Capone M., Querci V., Beltrame L., Cavalieri D., D'Aiuto E., Cimaz R., Nebbioso A., Liotta F., De Palma R., Maggi E., Cosmi L., Romagnani S., Annunziato F., Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. Immunity 2012 36 2 201 214 2-s2.0-84857444826 10.1016/j.immuni.2011.12.013
25. Ankathatti Munegowda M., Deng Y., Mulligan S. J., Xiang J., Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity. Cancer Immunology, Immunotherapy 2011 60 10 1473 1484 2-s2.0-80054121352 10.1007/s00262-011-1054-y
26. Pinto L. G., Cunha T. M., Vieira S. M., Lemos H. P., Verri W. A. Jr., Cunha F. Q., Ferreira S. H., IL-17 mediates articular hypernociception in antigen-induced arthritis in mice. Pain 2010 148 2 247 256 2-s2.0-74449086193 10.1016/j.pain.2009.11.006
27. Passos S. T., Silver J. S., O'Hara A. C., Sehy D., Stumhofer J. S., Hunter C. A., IL-6 promotes NK cell production of IL-17 during toxoplasmosis. Journal of Immunology 2010 184 4 1776 1783 2-s2.0-77949890873 10.4049/jimmunol.0901843
28. Sellge G., Magalhaes J. G., Konradt C., Fritz J. H., Salgado-Pabon W., Eberl G., Bandeira A., Di Santo J. P., Sansonetti P. J., Phalipon A., Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity. Journal of Immunology 2010 184 4 2076 2085 2-s2.0-77949900741 10.4049/jimmunol.0900978
29. Raffatellu M., Santos R. L., Verhoeven D. E., George M. D., Wilson R. P., Winter S. E., Godinez I., Sankaran S., Paixao T. A., Gordon M. A., Kolls J. K., Dandekar S., Bäumler A. J., Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nature Medicine 2008 14 4 421 428 2-s2.0-41849142985 10.1038/nm1743 (Pubitemid 351499394)
30. Riol-Blanco L., Lazarevic V., Awasthi A., Mitsdoerffer M., Wilson B. S., Croxford A., Waisman A., Kuchroo V. K., Glimcher L. H., Oukka M., IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections. Journal of Immunology 2010 184 4 1710 1720 2-s2.0-77949895907 10.4049/jimmunol.0902796
31. Dejima T., Shibata K., Yamada H., Hara H., Iwakura Y., Naito S., Yoshikai Y., Protective role of naturally occurring interleukin-17A-producing γ δ cells in the Lung at the early stage of systemic candidiasis in mice. Infection and Immunity 2011 79 11 4503 4510 2-s2.0-80855140152 10.1128/IAI.05799-11
32. Hueber A. J., Asquith D. L., Miller A. M., Reilly J., Kerr S., Leipe J., Melendez A. J., McInnes I. B., Cutting edge: mast cells express IL-17A in rheumatoid arthritis synovium. Journal of Immunology 2010 184 7 3336 3340 2-s2.0-77951636478 10.4049/jimmunol.0903566
33. Pötzl J., Botteron C., Tausch E., Pedré X., Mueller A. M., Männel D. N., Lechner A., Tracing functional antigen-specific CCR6+ Th17 cells after vaccination. PLoS ONE 2008 3 8 2-s2.0-51449086403 10.1371/journal.pone.0002951 e2951
34. Zhang X., Gao L., Lei L., Zhong Y., Dube P., Berton M. T., Arulanandam B., Zhang J., Zhong G., A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum. Journal of Immunology 2009 183 2 1291 1300 2-s2.0-70049112374 10.4049/jimmunol.0803075
35. Geddes K., Rubino S. J., Magalhaes J. G., Streutker C., Le Bourhis L., Cho J. H., Robertson S. J., Kim C. J., Kaul R., Philpott D. J., Girardin S. E., Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nature Medicine 2011 17 7 837 844 2-s2.0-79960131814 10.1038/nm.2391
36. Torchinsky M. B., Garaude J., Martin A. P., Blander J. M., Innate immune recognition of infected apoptotic cells directs T H17 cell differentiation. Nature 2009 458 7234 78 82 2-s2.0-61949472508 10.1038/nature07781
37. Martin B., Hirota K., Cua D. J., Stockinger B., Veldhoen M., Interleukin-17-producing γ δ T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009 31 2 321 330 2-s2.0-68649126866 10.1016/j.immuni.2009.06.020
38. Godinez I., Raffatellu M., Chu H., Paixão T. A., Haneda T., Santos R. L., Bevins C. L., Tsolis R. M., Bäumler A. J., Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype typhimurium in the intestine. Infection and Immunity 2009 77 1 387 398 2-s2.0-58449115208 10.1128/IAI.00933-08
39. Clapp B., Skyberg J. A., Yang X., Thornburg T., Walters N., Pascual W. P., Protective live oral brucellosis vaccines stimulate Th1 and Th17 cell responses. Infection and Immunity 2011 79 10 4165 4174 2-s2.0-80855127652 10.1128/IAI.05080-11
40. Ye P., Rodriguez F. H., Kanaly S., Stocking K. L., Schurr J., Schwarzenberger P., Oliver P., Huang W., Zhang P., Zhang J., Shellito J. E., Bagby G. J., Nelson S., Charrier K., Peschon J. J., Kolls J. K., Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. Journal of Experimental Medicine 2001 194 4 519 527 2-s2.0-17944364849 10.1084/jem.194.4.519 (Pubitemid 32835046)
41. Miyamoto M., Prause O., Sjöstrand M., Laan M., Lötvall J., Lindén A., Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. Journal of Immunology 2003 170 9 4665 4672 2-s2.0-0037406730 (Pubitemid 36519973)
42. Hoshino H., Laan M., Sjöstrand M., Lötvall J., Skoogh B. E., Linden A., Increased elastase andmyeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo. Journal of Allergy and Clinical Immunology 2000 105 1 143 149 (Pubitemid 30059114)
43. Puel A., Cypowyj S., Bustamante J., Wright J. F., Liu L., Lim H. K., Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011 332 6025 65 68 2-s2.0-79953284685 10.1126/science. 1200439
44. Liu L., Okada S., Kong X.-F., Kreins A. Y., Cypowyj S., Abhyankar A., Toubiana J., Itan Y., Audry M., Nitschke P., Masson C., Toth B., Flatot J., Migaud M., Chrabieh M., Kochetkov T., Bolze A., Borghesi A., Toulon A., Hiller J., Eyerich S., Eyerich K., Gulácsy V., Chernyshova L., Chernyshov V., Bondarenko A., Grimaldo R. M. C., Blancas-Galicia L., Beas I. M. M., Roesler J., Magdorf K., Engelhard D., Thumerelle C., Burgel P.-R., Hoernes M., Drexel B., Seger R., Kusuma T., Jansson A. F., Sawalle-Belohradsky J., Belohradsky B., Jouanguy E., Bustamante J., Bué M., Karin N., Wildbaum G., Bodemer C., Lortholary O., Fischer A., Blanche S., Al-Muhsen S., Reichenbach J., Kobayashi M., Rosales F. E., Lozano C. T., Kilic S. S., Oleastro M., Etzioni A., Traidl-Hoffmann C., Renner E. D., Abel L., Picard C., Maródi L., Boisson-Dupuis S., Puel A., Casanova J.-L., Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. Journal of Experimental Medicine 2011 208 18 1635 1648 2-s2.0-79961154447 10.1084/jem.20110958
45. Kisand K., Bøe Wolff A. S., Podkrajsek K. T., Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. Journal of Experimental Medicine 2010 207 2 299 308
46. Puel A., Döffinger R., Natividad A., Chrabieh M., Barcenas-Morales G., Picard C., Cobat A., Ouachée-Chardin M., Toulon A., Bustamante J., Al-Muhsen S., Al-Owain M., Arkwright P. D., Costigan C., McConnell V., Cant A. J., Abinun M., Polak M., Bougnères P.-F., Kumararatne D., Marodi L., Nahum A., Roifman C., Blanche S., Fischer A., Bodemer C., Abel L., Lilic D., Casanova J.-L., Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. Journal of Experimental Medicine 2010 207 2 291 297 2-s2.0-77149124612 10.1084/jem.20091983
47. Muñoz M., Heimesaat M. M., Danker K., Struck D., Lohmann U., Plickert R., Bereswill S., Fischer A., Dunay I. R., Wolk K., Loddenkemper C., Krell H.-W., Libert C., Lund L. R., Frey O., Hölscher C., Iwakura Y., Ghilardi N., Ouyang W., Kamradt T., Sabat R., Liesenfeld O., Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. Journal of Experimental Medicine 2009 206 13 3047 3059 2-s2.0-73949103213 10.1084/jem.20090900
48. Trifari S., Kaplan C. D., Tran E. H., Crellin N. K., Spits H., Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells. Nature Immunology 2009 10 8 864 871 2-s2.0-67651171182 10.1038/ni.1770
49. Eyerich S., Eyerich K., Pennino D., Carbone T., Nasorri F., Pallotta S., Cianfarani F., Odorisio T., Traidl-Hoffmann C., Behrendt H., Durham S. R., Schmidt-Weber C. B., Cavani A., Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. Journal of Clinical Investigation 2009 119 12 3573 3585 2-s2.0-72849131815 10.1172/JCI40202
50. Eyerich S., Wagener J., Wenzel V., Scarponi C., Pennino D., Albanesi C., Schaller M., Behrendt H., Ring J., Schmidt-Weber C. B., Cavani A., Mempel M., Traidl-Hoffmann C., Eyerich K., IL-22 and TNF- α represent a key cytokine combination for epidermal integrity during infection with Candida albicans. European Journal of Immunology 2011 41 7 1894 1901 2-s2.0-79959724313 10.1002/eji.201041197
51. Liang S. C., Nickerson-Nutter C., Pittman D. D., Carrier Y., Goodwin D. G., Shields K. M., Lambert A.-J., Schelling S. H., Medley Q. G., Ma H.-L., Collins M., Dunussi-Joannopoulos K., Fouser L. A., IL-22 induces an acute-phase response. Journal of Immunology 2010 185 9 5531 5538 2-s2.0-78149487314 10.4049/jimmunol.0904091
52. Kudva A., Scheller E. V., Robinson K. M., Crowe C. R., Choi S. M., Slight S. R., Khader S. A., Dubin P. J., Enelow R. I., Kolls J. K., Alcorn J. F., Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. Journal of Immunology 2011 186 3 1666 1674 2-s2.0-79251548900 10.4049/jimmunol.1002194
53. Zhang Y., Cobleigh M. A., Lian J.-Q., Huang C.-X., Booth C. J., Bai X.-F., Robek M. D., A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology 2011 141 5 1897 1906 2-s2.0-80054847781 10.1053/j.gastro.2011.06.051
54. Zenewicz L. A., Yancopoulos G. D., Valenzuela D. M., Murphy A. J., Stevens S., Flavell R. A., Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008 29 6 947 957 2-s2.0-57449090428 10.1016/j.immuni.2008.11.003
55. Miyamoto M., Emoto M., Emoto Y., Brinkmann V., Yoshizawa I., Seiler P., Aichele P., Kita E., Kaufmann S. H. E., Neutrophilia in LFA-1-deficient mice confers resistance to listeriosis: possible contribution of granulocyte-colony- stimulating factor and IL-17. Journal of Immunology 2003 170 10 5228 5234 2-s2.0-0038326555 (Pubitemid 36554756)
56. Orgun N. N., Mathis M. A., Wilson C. B., Sing S. W., Deviation from a strong Th1-dominated to a modest Th17-dominated CD4 T cell response in the absence of IL-12p40 and type I IFNs sustains protective CD8 T cells. Journal of Immunology 2008 180 6 4109 4115 2-s2.0-44849133333
57. Bai H., Cheng J., Gao X., Joyee A. G., Fan Y., Wang S., Jiao L., Yao Z., Yang X., IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. Journal of Immunology 2009 183 9 5886 5895 2-s2.0-77951227349 10.4049/jimmunol.0901584
58. Zhou X., Chen Q., Moore J., Kolls J. K., Halperin S., Wang J., Critical role of the interleukin-17/interleukin-17 receptor axis in regulating host susceptibility to respiratory infection with Chlamydia species. Infection and Immunity 2009 77 11 5059 5070 2-s2.0-70350461417 10.1128/IAI.00403-09
59. Minegishi Y., Saito M., Nagasawa M., Takada H., Hara T., Tsuchiya S., Agematsu K., Yamada M., Kawamura N., Ariga T., Tsuge I., Karasuyama H., Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. Journal of Experimental Medicine 2009 206 6 1291 1301 2-s2.0-67449149963 10.1084/jem.20082767
60. Sieve A. N., Meeks K. D., Bodhankar S., Lee S., Kolls J. K., Simecka J. W., Berg R. E., A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection. European Journal of Immunology 2009 39 2 426 438 2-s2.0-60749095713 10.1002/eji.200838726
61. Khader S. A., Bell G. K., Pearl J. E., Fountain J. J., Rangel-Moreno J., Cilley G. E., Shen F., Eaton S. M., Gaffen S. L., Swain S. L., Locksley R. M., Haynes L., Randall T. D., Cooper A. M., IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nature Immunology 2007 8 4 369 377 2-s2.0-34248562792 10.1038/ni1449 (Pubitemid 46745412)
62. Holley M. M., Kielian T., Th1 and Th17 cells regulate innate immune responses and bacterial clearance during central nervous system infection. Journal of Immunology 2012 188 3 1360 1370 2-s2.0-84856567062 10.4049/jimmunol.1101660
63. Salgado M., Rallón N. I., Rodés B., López M., Soriano V., Benito J. M., Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors. Clinical Immunology 2011 139 2 110 114 2-s2.0-79954568221 10.1016/j.clim.2011.02.008
64. Ivanov I. I., Atarashi K., Manel N., Brodie E. L., Shima T., Karaoz U., Wei D., Goldfarb K. C., Santee C. A., Lynch S. V., Tanoue T., Imaoka A., Itoh K., Takeda K., Umesaki Y., Honda K., Littman D. R., Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009 139 3 485 498 2-s2.0-70350343544 10.1016/j.cell.2009.09.033
65. Wu H.-J., Ivanov I. I., Darce J., Hattori K., Shima T., Umesaki Y., Littman D. R., Benoist C., Mathis D., Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010 32 6 815 827 2-s2.0-77953913586 10.1016/j.immuni.2010.06.001
66. Abraham C., Medzhitov R., Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 2011 140 6 1729 1737 2-s2.0-79955552936 10.1053/j.gastro.2011.02.012
67. Kwok S.-K., Cho M.-L., Her Y.-M., Oh H.-J., Park M.-K., Lee S.-Y., Woo Y. J., Ju J. H., Park K.-S., Kim H.-Y., Park S.-H., TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome. Arthritis Research and Therapy 2012 14 2, article R64 2-s2.0-84858012918 10.1186/ar3780
68. Ciccia F., Guggino G., Rizzo A., Ferrante A., Raimondo S., Giardina A., Dieli F., Campisi G., Alessandro R., Triolo G., Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjögren's syndrome. Annals of the Rheumatic Diseases 2012 71 2 295 301 2-s2.0-84855350256 10.1136/ard.2011.154013
69. Abdulahad W. H., Kroese F. G. M., Vissink A., Bootsma H., Immune regulation and B-cell depletion therapy in patients with primary Sjögren's syndrome. Journal of Autoimmunity 2012 39 103 111 2-s2.0-84856790672 10.1016/j.jaut.2012.01.009
70. Zupan J., Komadina R., Marc J., The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. Journal of Biomedical Science 2012 19 1, article 28 2-s2.0-84857615261 10.1186/1423-0127-19-28
71. Oostlander A. E., Everts V., Schoenmaker T., Bravenboer N., Van Vliet S. J., Van Bodegraven A. A., Lips P., De Vries T. J., T cell-mediated increased osteoclast formation from peripheral blood as a mechanism for crohn's disease-associated bone loss. Journal of Cellular Biochemistry 2012 113 1 260 268 2-s2.0-84055218377 10.1002/jcb.23352
72. Goswami J., Hernández-Santos N., Zuniga L. A., Gaffen S. L., A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. European Journal of Immunology 2009 39 10 2831 2839 2-s2.0-70350545726 10.1002/eji.200939670
73. Yuan F.-L., Li X., Lu W.-G., Zhao Y.-Q., Li C.-W., Li J.-P., Sun J.-M., Xu R.-S., Type 17 T-helper cells might be a promising therapeutic target for osteoporosis. Molecular Biology Reports 2012 39 1 771 774 2-s2.0-84855192948 10.1007/s11033-011-0797-z
74. Won H. Y., Lee J.-A., Park Z. S., Song J. S., Kim H. Y., Jang S.-M., Yoo S.-E., Rhee Y., Hwang E. S., Bae M. A., Prominent bone loss mediated by RANKL and IL-17 produced by CD4+ T cells in tallyho/JngJ mice. PLoS ONE 2011 6 3 2-s2.0-79953034578 10.1371/journal.pone.0018168 e18168
75. Toussirot É., The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases. Inflammation and Allergy 2012 11 2 159 168 2-s2.0-84857774124
76. Putila J. J., Guo N. L., Association of arsenic exposure with lung cancer incidence rates in the United States. PLoS ONE 2011 6 10 2-s2.0-80053921372 10.1371/journal.pone.0025886 e25886
77. Bock K. W., Köhle C., Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochemical Pharmacology 2006 72 4 393 404 2-s2.0-33745965633 10.1016/j.bcp.2006.01.017 (Pubitemid 44061741)
78. Elbekai R. H., El-Kadi A. O. S., Modulation of aryl hydrocarbon receptor-regulated gene expression by arsenite, cadmium, and chromium. Toxicology 2004 202 3 249 269 2-s2.0-4444366272 10.1016/j.tox.2004.05.009 (Pubitemid 39165399)
79. Kluxen F. M., Höfer N., Kretzschmar G., Degen G. H., Diel P., Cadmium modulates expression of aryl hydrocarbon receptor-associated genes in rat uterus by interaction with the estrogen receptor. Archives of Toxicology 2012 86 591 601 2-s2.0-82155178727 10.1007/s00204-011-0787-x
80. Korashy H. M., El-Kadi A. O. S., Transcriptional and posttranslational mechanisms modulating the expression of the cytochrome P450 1A1 gene by lead in HepG2 cells: a role of heme oxygenase. Toxicology 2012 291 1-3 113 121 2-s2.0-84155163052 10.1016/j.tox.2011.11.006
81. Quintana F. J., Basso A. S., Iglesias A. H., Korn T., Farez M. F., Bettelli E., Caccamo M., Oukka M., Weiner H. L., Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008 453 7191 65 71 2-s2.0-42649095378 10.1038/nature06880 (Pubitemid 351630328)
82. Veldhoen M., Hirota K., Westendorf A. M., Buer J., Dumoutier L., Renauld J.-C., Stockinger B., The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008 453 7191 106 109 2-s2.0-42649106556 10.1038/nature06881 (Pubitemid 351630329)
83. Vogel C. F. A., Goth S. R., Dong B., Pessah I. N., Matsumura F., Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochemical and Biophysical Research Communications 2008 375 3 331 335 2-s2.0-50949098849 10.1016/j.bbrc.2008.07.156
84. DiNatale B. C., Murray I. A., Schroeder J. C., Flaveny C. A., Lahoti T. S., Laurenzana E. M., Omiecinski C. J., Perdew G. H., Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicological Sciences 2010 115 1 89 97 2-s2.0-79551688725 10.1093/toxsci/kfq024
85. Ramirez J.-M., Brembilla N. C., Sorg O., Chicheportiche R., Matthes T., Dayer J.-M., Saurat J.-H., Roosnek E., Chizzolini C., Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. European Journal of Immunology 2010 40 9 2450 2459 2-s2.0-77956469491 10.1002/eji.201040461
86. Baranowska-Bosiacka I., Gutowska I., Marchlewicz M., Marchetti C., Kurzawski M., Dziedziejko V., Kolasa A., Olszewska M., Rybicka M., Safranow K., Nowacki P., Wiszniewska B., Chlubek D., Disrupted pro- and antioxidative balance as a mechanism of neurotoxicity induced by perinatal exposure to lead. Brain Research 2012 1435 56 71 2-s2.0-84856389201 10.1016/j.brainres.2011.11.062
87. Oguzturk H., Ciftci O., Aydin M., Timurkaan N., Beytur A., Yilmaz F., Ameliorative effects of curcumin against acute cadmium toxicity on male reproductive system in rats. Andrologia 2012 44 243 249
88. Thévenod F., Cadmium and cellular signaling cascades: to be or not to be? Toxicology and Applied Pharmacology 2009 238 3 221 239 2-s2.0-63049091896 10.1016/j.taap.2009.01.013
89. Galazyn-Sidorczuk M., Brzóska M. M., Rogalska J., Roszczenko A., Jurczuk M., Effect of zinc supplementation on glutathione peroxidase activity and selenium concentration in the serum, liver and kidney of rats chronically exposed to cadmium. Journal of Trace Elements in Medicine and Biology 2012 26 1 46 52 2-s2.0-84857796451 10.1016/j.jtemb.2011.10.002
90. Pal M., Ghosh M., Studies on comparative efficacy of α -linolenic acid and α -eleostearic acid on prevention of organic mercury-induced oxidative stress in kidney and liver of rat. Food and Chemical Toxicology 2012 50 3-4 1066 1072 2-s2.0-84856457754 10.1016/j.fct.2011.12.042
91. Tellez-Plaza M., Navas-Acien A., Caldwell K. L., Menke A., Muntner P., Guallar E., Reduction in cadmium exposure in the United States population, 1988-2008: the contribution of declining smoking rates. Environmental Health Perspectives 2012 120 2 204 209 2-s2.0-84856715803 10.1289/ehp.1104020
92. Armstrong A. W., Armstrong E. J., Fuller E. N., Sockolov M. E., Voyles S. V., Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms. British Journal of Dermatology 2011 165 6 1162 1168 2-s2.0-82255175512 10.1111/j.1365-2133.2011.10526.x
93. Attwa E., Swelam E., Relationship between smoking-induced oxidative stress and the clinical severity of psoriasis. Journal of the European Academy of Dermatology and Venereology 2011 25 7 782 787 2-s2.0-79955629224 10.1111/j.1468-3083.2010.03860.x
94. Khor B., Gardet A., Xavier R. J., Genetics and pathogenesis of inflammatory bowel disease. Nature 2011 474 7351 307 317 2-s2.0-79959216005 10.1038/nature10209
95. Zhu H., Li Y. R., Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Experimental Biology and Medicine 2012 237 5 474 480
96. Yamamoto T., Autoimmune mechanisms of scleroderma and a role of oxidative stress. Self/Nonself 2011 2 1 4 10 2-s2.0-79960380532 10.4161/self.2.1.14058
97. Mathis K. W., Venegas-Pont M., Masterson C. W., Stewart N. J., Wasson K. L., Ryan M. J., Oxidative stress promotes hypertension and albuminuria during the autoimmune disease systemic lupus erythematosus. Hypertension 2012 59 3 673 679 2-s2.0-84857636232 10.1161/HYPERTENSIONAHA.111.190009
98. Gabr S. A., Al-Ghadir A. H., Role of cellular oxidative stress and cytochrome c in the pathogenesis of psoriasis. Archives of Dermatological Research 2012 304 6 451 457 2-s2.0-84858029018 10.1007/s00403-012-1230-8
99. Profumo E., Buttari B., Rigano R., Oxidative stress in cardiovascular inflammation: its involvement in autoimmune responses. International Journal of Inflammation 2011 2011 6 295705
100. Íşman Ç. A., Yeen B. Ç., Alican Í., Methimazole-induced hypothyroidism in rats ameliorates oxidative injury in exprerimental colitis. Journal of Endocrinology 2003 177 3 471 476 2-s2.0-0037701714 10.1677/joe.0.1770471 (Pubitemid 36722303)
101. Castellani R. J., Moreira P. I., Perry G., Zhu X., The role of iron as a mediator of oxidative stress in Alzheimer disease. BioFactors 2012 38 2 133 138 2-s2.0-84859420934 10.1002/biof.1010
102. Abraham N. G., Kappas A., Pharmacological and clinical aspects of heme oxygenase. Pharmacological Reviews 2008 60 1 79 127 2-s2.0-41149177025 10.1124/pr.107.07104 (Pubitemid 351439218)
103. Fagone P., Mangano K., Coco M., Perciavalle V., Garotta G., Romao C. C., Nicoletti F., Therapeutic potential of carbon monoxide in multiple sclerosis. Clinical and Experimental Immunology 2012 167 2 179 187 2-s2.0-84855798185 10.1111/j.1365-2249.2011.04491.x
104. Khor T. O., Huang M.-T., Kwon K. H., Chan J. Y., Reddy B. S., Kong A.-N., Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Research 2006 66 24 11580 11584 2-s2.0-33846264538 10.1158/0008-5472.CAN-06-3562 (Pubitemid 46094166)
105. Esworthy R. S., Aranda R., Martín M. G., Binder J. H., Doroshow S. W., Chu F.-F., Mice with combined disruption of gpx1 and gpx2 genes have colitis. The American Journal of Physiology 2001 281 3 G848 G855 2-s2.0-0034822194
106. Santel T., Pflug G., Hemdan N. Y. A., Schäfer A., Hollenbach M., Buchold M., Hintersdorf A., Linder I., Otto A., Bigl M., Oerlecke I., Hutschenreuter A., Sack U., Huse K., Groth M., Birkemeyer C., Schellenberger W., Gebhardt R., Platzer M., Weiss T., Yijayalakshmi M. A., Krüger M., Birkenmeier G., Curcumin inhibits glyoxalase 1: a possible link to its anti-inflammatory and anti-tumor activity. PLoS ONE 2008 3 10 2-s2.0-55649097940 10.1371/journal.pone.0003508 e3508
107. Chen C.-C., Chen H.-L., Hsieh C.-W., Yang Y.-L., Wung B.-S., Upregulation of NF-E2-related factor-2-dependent glutathione by carnosol provokes a cytoprotective response and enhances cell survival. Acta Pharmacologica Sinica 2011 32 1 62 69 2-s2.0-78651105011 10.1038/aps.2010.181
108. Olsen T., Rismo R., Cui G., Goll R., Christiansen I., Florholmen J., TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation. Cytokine 2011 56 3 633 640 2-s2.0-80655122800 10.1016/j.cyto.2011.08.036
109. Kida H., Yoshida M., Hoshino S., Inoue K., Yano Y., Yanagita M., Kumagai T., Osaki T., Tachibana I., Saeki Y., Kawase I., Protective effect of IL-6 on alveolar epithelial cell death induced by hydrogen peroxide. The American Journal of Physiology 2005 288 2 L342 L349 2-s2.0-19944427139 10.1152/ajplung.00016.2004 (Pubitemid 40105373)
110. Ghoreschi K., Brück J., Kellerer C., Deng C., Peng H., Rothfuss O., Hussain R. Z., Gocke A. R., Respa A., Glocova I., Valtcheva N., Alexander E., Feil S., Feil R., Schulze-Osthoff K., Rupec R. A., Lovett-Racke A. E., Dringen R., Racke M. K., Röcken M., Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. Journal of Experimental Medicine 2011 208 11 2291 2303 2-s2.0-80055106751 10.1084/jem.20100977
111. Napolitano J. R., Liu M.-J., Bao S., Crawford M., Nana-Sinkam P., Cormet-Boyaka E., Knoell D. L., Cadmium-mediated toxicity of lung epithelia is enhanced through NF- B-mediated transcriptional activation of the human zinc transporter ZIP8. The American Journal of Physiology 2012 302 9 L909 L918 2-s2.0-84860540850 10.1152/ajplung.00351.2011
112. Bao B., Thakur A., Li Y., Ahmad A., Azmi A. S., Banerjee S., Kong D., Ali S., Lum L. G., Sarkar F. H., The immunological contribution of NF- B within the tumor microenvironment: a potential protective role of zinc as an anti-tumor agent. Biochimica et Biophysica Acta 2012 1825 2 160 172 2-s2.0-84455167526 10.1016/j.bbcan.2011.11.002
113. Li L., Huang L., Vergis A. L., Ye H., Bajwa A., Narayan V., Strieter R. M., Rosin D. L., Okusa M. D., IL-17 produced by neutrophils regulates IFN- γ -mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. Journal of Clinical Investigation 2010 120 1 331 342 2-s2.0-74949108768 10.1172/JCI38702
114. Doreau A., Belot A., Bastid J., Riche B., Trescol-Biemont M.-C., Ranchin B., Fabien N., Cochat P., Pouteil-Noble C., Trolliet P., Durieu I., Tebib J., Kassai B., Ansieau S., Puisieux A., Eliaou J.-F., Bonnefoy-Bérard N., Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nature Immunology 2009 10 7 778 785 2-s2.0-67649197343 10.1038/ni.1741
115. Lindner I., Hemdan N. Y. A., Buchold M., α 2-macroglobulin inhibits the malignant properties of astrocytoma cells by impeding β -catenin signaling. Cancer Research 2010 70 4 277 287 2-s2.0-76749132076 10.1158/0008-5472.CAN-10-0036
116. Sønder S. U., Saret S., Tang W., Sturdevant D. E., Porcella S. F., Siebenlist U., IL-17-induced NF- B activation via CIKS/Act1 physiologic significance and signaling mechanisms. Journal of Biological Chemistry 2011 286 15 12881 12890 2-s2.0-79953905619 10.1074/jbc.M110.199547
117. Kitabayashi C., Fukada T., Kanamoto M., Ohashi W., Hojyo S., Atsumi T., Ueda N., Azuma I., Hirota H., Murakami M., Hirano T., Zinc suppresses Th17 development via inhibition of STAT3 activation. International Immunology 2010 22 5 375 386 2-s2.0-77953993126 10.1093/intimm/dxq017
118. Simonian P. L., Roark C. L., Wehrmann F., Lanham A. M., Born W. K., O'Brien R. L., Fontenot A. P., IL-17A-expressing T cells are essential for bacterial clearance in a murine model of hypersensitivity pneumonitis. Journal of Immunology 2009 182 10 6540 6549 2-s2.0-70349946374 10.4049/jimmunol.0900013
119. Woolard M. D., Hensley L. L., Kawula T. H., Frelinger J. A., Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells. Infection and Immunity 2008 76 6 2651 2659 2-s2.0-46249101937 10.1128/IAI.01412-07
120. Joshi A. D., Fong D. J., Oak S. R., Trujillo G., Flaherty K. R., Martinez F. J., Hogaboam C. M., Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitis. The American Journal of Respiratory and Critical Care Medicine 2009 179 8 705 716 2-s2.0-65249134949 10.1164/rccm.200811-1700OC
121. Simonian P. L., Roark C. L., Wehrmann F., Lanham A. K., Del Valle F. D., Born W. K., O'Brien R. L., Fontenot A. P., Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis. Journal of Immunology 2009 182 1 657 665 2-s2.0-59849115870
122. Wang F., Xu J., Liao Y., Wang Y., Liu C., Zhu X., Chen Z. K., Sun Z., Tim-3 ligand galectin-9 reduces IL-17 level and accelerates Klebsiella pneumoniae infection. Cellular Immunology 2011 269 1 22 28 2-s2.0-79955465042 10.1016/j.cellimm.2011.03.005
123. Chen X., Zhang M., Liao M., Graner M. W., Wu C., Yang Q., Liu H., Zhou B., Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T cells. The American Journal of Respiratory and Critical Care Medicine 2010 181 7 734 742 2-s2.0-77951905021 10.1164/rccm.200909-1463OC
124. Liu Z., Yang L., Cui Y., Wang X., Guo C., Huang Z., Kan Q., Liu Z., Liu Y., IL-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease. Inflammatory Bowel Diseases 2009 15 8 1133 1144 2-s2.0-66149159613 10.1002/ibd.20923
125. Sugihara T., Kobori A., Imaeda H., Tsujikawa T., Amagase K., Takeuchi K., Fujiyama Y., Andoh A., The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease. Clinical and Experimental Immunology 2010 160 3 386 393 2-s2.0-77952222918 10.1111/j.1365-2249.2010.04093. x
126. Kelly M. N., Kolls J. K., Happel K., Schwartzman J. D., Schwarzenberger P., Combe C., Moretto M., Khan I. A., Interteukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infection and Immunity 2005 73 1 617 621 2-s2.0-11144286392 10.1128/IAI.73.1.617-621.2005 (Pubitemid 40041158)
127. Werner J. L., Metz A. E., Horn D., Schoeb T. R., Hewitt M. M., Schwiebert L. M., Faro-Trindade I., Brown G. D., Steele C., Requisite role for the dectin-1 β -glucan receptor in pulmonary defense against aspergillus fumigatus. Journal of Immunology 2009 182 8 4938 4946 2-s2.0-65249187409 10.4049/jimmunol.0804250
128. Jin Y.-H., Kang H. S., Mohindru M., Kim B. S., Preferential induction of protective T cell responses to Theiler's virus in resistant (C57BL/6 X SJL)F1 mice. Journal of Virology 2011 85 6 3033 3040 2-s2.0-79952424540 10.1128/JVI.02400-10
129. Mukherjee S., Lindell D. M., Berlin A. A., Morris S. B., Shanley T. P., Hershenson M. B., Lukacs N. W., IL-17Induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. The American Journal of Pathology 2011 179 1 248 258 2-s2.0-80052508971 10.1016/j.ajpath. 2011.03.003
130. Huang Z., van Velkinburgh J. C., Ni B., Wu Y., Pivotal roles of the interleukin-23/T helper 17 cell axis in hepatitis B. Liver International 2012 32 894 901 2-s2.0-84857132099 10.1111/j.1478-3231.2012.02764.x
131. Jimenez-Sousa M. A., Almansa R., de la Fuente C., Caro-Paton A., Ruiz L., Sanchez-Antolín G., Gonzalez J. M., Aller R., Alcaide N., Largo P., Resino S., Ortiz De Lejarazu R., Bermejo-Martin J. F., Increased Th1, Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin. European Cytokine Network 2010 21 2 84 91 2-s2.0-77953878541 10.1684/ecn.2010.0191
132. Campillo-Gimenez L., Cumont M.-C., Fay M., Kared H., Monceaux V., Diop O., Müller-Trutwin M., Hurtrel B., Lévy Y., Zaunders J., Dy M., Leite-de-Moraes M. C., Elbim C., Estaquier J., AIDS progression is associated with the emergence of IL-17-producing cells early after simian immunodeficiency virus infection. Journal of Immunology 2010 184 2 984 992 2-s2.0-76249128095 10.4049/jimmunol.0902316
133. Elhed A., Unutmaz D., Th17 cells and HIV infection. Current Opinion in HIV and AIDS 2010 5 2 146 150 2-s2.0-76949098433 10.1097/COH.0b013e32833647a8
134. Chege D., Sheth P. M., Kain T., Kim C. J., Kovacs C., Loutfy M., Halpenny R., Kandel G., Chun T.-W., Ostrowski M., Kaul R., Yi T. J., Huibner S., Mujib S., Persad D., Benko E., Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy. AIDS 2011 25 6 741 749 2-s2.0-79953735335 10.1097/QAD.0b013e328344cefb
135. Suryawanshi A., Veiga-Parga T., Rajasagi N. K., Reddy P. B. J., Sehrawat S., Sharma S., Rouse B. T., Role of il-17 and th17 cells in herpes simplex virus-induced corneal immunopathology. Journal of Immunology 2011 187 4 1919 1930 2-s2.0-80051935234 10.4049/jimmunol.1100736
136. Fu Y., Wang W., Tong J., Th17: a new participant in gut dysfunction in mice infected with trichinella spiralis. Mediators of Inflammation 2009 2009 7 2-s2.0-71449086148 10.1155/2009/517052 517052